Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy

M. Tiribelli; E. Abruzzese; I. Capodanno; Federica Sora'; E. Trabacchi; A. Iurlo; L. Luciano; G. Binotto; M. Bonifacio; M. Annunziata; M. Crugnola; R. Fanin

doi:10.1007/s00277-019-03802-y

Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy

M. Tiribelli^*
, E. Abruzzese
, I. Capodanno
, Federica Sora'
, E. Trabacchi
, A. Iurlo
, L. Luciano
, G. Binotto
, M. Bonifacio
, M. Annunziata
, M. Crugnola
, R. Fanin

^*Autore corrispondente per questo lavoro

University of Udine
University of Rome Tor Vergata
IRCCS Azienda Unità Sanitaria Locale di Reggio Emilia
Ospedale Guglielmo da Saliceto
IRCCS Fondazione Ca'Granda – Ospedale Maggiore Policlinico - Milano
Azienda Ospedaliera Universitaria Federico II
University of Padua
University of Verona
Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli
Azienda Ospedaliero - Universitaria di Parma

Risultato della ricerca: Contributo in rivista › Abstract di Conferenza

7 Citazioni (Scopus)

Abstract

no abs

Lingua originale	Inglese
pagine (da-a)	2609-2611
Numero di pagine	3
Rivista	Annals of Hematology
Volume	98
Numero di pubblicazione	11
DOI	https://doi.org/10.1007/s00277-019-03802-y
Stato di pubblicazione	Pubblicato - 2019

All Science Journal Classification (ASJC) codes

Ematologia

Keywords

80 and over
Aged
Aniline Compounds
BCR-ABL Positive
Chronic
Dasatinib
Female
Humans
Italy
Leukemia
Male
Malignant
Middle Aged
Myelogenous
Nitriles
Pleural Effusion
Quinolines
Retrospective Studies

Accesso al documento

10.1007/s00277-019-03802-y

Altri file e collegamenti

Cita questo

Tiribelli, M., Abruzzese, E., Capodanno, I., Sora', F., Trabacchi, E., Iurlo, A., Luciano, L., Binotto, G., Bonifacio, M., Annunziata, M., Crugnola, M., & Fanin, R. (2019). Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy. Annals of Hematology, 98(11), 2609-2611. https://doi.org/10.1007/s00277-019-03802-y

@article{593b098a51534d95b6a59a772b523bb0,

title = "Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy",

abstract = "no abs",

keywords = "80 and over, Aged, Aniline Compounds, BCR-ABL Positive, Chronic, Dasatinib, Female, Humans, Italy, Leukemia, Male, Malignant, Middle Aged, Myelogenous, Nitriles, Pleural Effusion, Quinolines, Retrospective Studies, 80 and over, Aged, Aniline Compounds, BCR-ABL Positive, Chronic, Dasatinib, Female, Humans, Italy, Leukemia, Male, Malignant, Middle Aged, Myelogenous, Nitriles, Pleural Effusion, Quinolines, Retrospective Studies",

author = "M. Tiribelli and E. Abruzzese and I. Capodanno and Federica Sora' and E. Trabacchi and A. Iurlo and L. Luciano and G. Binotto and M. Bonifacio and M. Annunziata and M. Crugnola and R. Fanin",

year = "2019",

doi = "10.1007/s00277-019-03802-y",

language = "English",

volume = "98",

pages = "2609--2611",

journal = "Annals of Hematology",

issn = "0939-5555",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "11",

}

Tiribelli, M, Abruzzese, E, Capodanno, I, Sora', F, Trabacchi, E, Iurlo, A, Luciano, L, Binotto, G, Bonifacio, M, Annunziata, M, Crugnola, M & Fanin, R 2019, 'Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy', Annals of Hematology, vol. 98, n. 11, pagg. 2609-2611. https://doi.org/10.1007/s00277-019-03802-y

TY - JOUR

T1 - Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy

AU - Tiribelli, M.

AU - Abruzzese, E.

AU - Capodanno, I.

AU - Sora', Federica

AU - Trabacchi, E.

AU - Iurlo, A.

AU - Luciano, L.

AU - Binotto, G.

AU - Bonifacio, M.

AU - Annunziata, M.

AU - Crugnola, M.

AU - Fanin, R.

PY - 2019

Y1 - 2019

N2 - no abs

AB - no abs

KW - 80 and over

KW - Aged

KW - Aniline Compounds

KW - BCR-ABL Positive

KW - Chronic

KW - Dasatinib

KW - Female

KW - Humans

KW - Italy

KW - Leukemia

KW - Male

KW - Malignant

KW - Middle Aged

KW - Myelogenous

KW - Nitriles

KW - Pleural Effusion

KW - Quinolines

KW - Retrospective Studies

KW - 80 and over

KW - Aged

KW - Aniline Compounds

KW - BCR-ABL Positive

KW - Chronic

KW - Dasatinib

KW - Female

KW - Humans

KW - Italy

KW - Leukemia

KW - Male

KW - Malignant

KW - Middle Aged

KW - Myelogenous

KW - Nitriles

KW - Pleural Effusion

KW - Quinolines

KW - Retrospective Studies

UR - https://publicatt.unicatt.it/handle/10807/147279

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85073827648&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85073827648&origin=inward

U2 - 10.1007/s00277-019-03802-y

DO - 10.1007/s00277-019-03802-y

M3 - Meeting Abstract

SN - 0939-5555

VL - 98

SP - 2609

EP - 2611

JO - Annals of Hematology

JF - Annals of Hematology

IS - 11

ER -

Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo